Hypoxia stimulates CXCR4 signalling in ileal carcinoids

Endocrine-Related Cancer

Volumn 17, Issue 2, 2010, Pages 303-316

  Arvidsson, Yvonne ^a   Bergström, Anders ^a   Arvidsson, Linda ^a   Kristiansson, Erik ^a,b   Ahlman, Håkan ^a   Nilsson, Ola ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CARCINOID; CELL HYPOXIA; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; ILEUM CANCER; MALE; MESENCHYME CELL; METASTASIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; TUMOR BIOPSY; UPREGULATION;

AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARBONIC ANHYDRASES; CARCINOID TUMOR; CELL HYPOXIA; CHEMOKINE CXCL12; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ILEAL NEOPLASMS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, CXCR4; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77950838545     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0085     Document Type: Article

References (52)

1. Aprelikova O, Wood M, Tackett S, Chandramouli GV & Barrett JC 2006 Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Research 66 5641-5647.
2. Arvidsson Y, Andersson E, Bergström A, Andersson MK, Altiparmak G, Illerskog AC, Ahlman H, Lamazhapova D & Nilsson O 2008 Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract. Endocrine-Related Cancer 15 569-581.
3. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT et al. 2000 Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genetics 25 25-29.
4. Baggiolini M 1998 Chemokines and leukocyte traffic. Nature 392 565-568.
5. Balkwill F 2004 The significance of cancer cell expression of the chemokine receptor CXCR4. Seminars in Cancer Biology 14 171-179.
6. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A & Springer TA 1996 A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). Journal of Experimental Medicine 184 1101-1109.
7. Bowen KA, Silva SR, Johnson JN, Doan HQ, Jackson LN, Gulhati P, Qiu S, Riall TS & Evers BM 2009 An analysis of trends and growth factor receptor expression of GI carcinoid tumors. Journal of Gastrointestinal Surgery 13 1773-1780.
8. Brizel DM, Rosner GL, Prosnitz LR & Dewhirst MW 1995 Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. International Journal of Radiation Oncology, Biology, Physics 32 1121-1125.
9. Brown JM & Wilson WR 2004 Exploiting tumour hypoxia in cancer treatment. Nature Reviews. Cancer 4 437-447.
10. Burger JA & Kipps TJ 2006 CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107 1761-1767.
11. Burger M, Glodek A, Hartmann T, Schmitt-Graff A, Silberstein LE, Fujii N, Kipps TJ & Burger JA 2003 Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22 8093-8101.
12. Chambers AF, Groom AC & MacDonald IC 2002 Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer 2 563-572.
13. Chaudhry A, Oberg K, Gobl A, Heldin CH & Funa K 1994 Expression of transforming growth factors beta 1, beta 2, beta 3 in neuroendocrine tumors of the digestive system. Anticancer Research 14 2085-2091.
14. Chou YT, Wang H, Chen Y, Danielpour D & Yang YC 2006 Cited2 modulates TGF-β-mediated upregulation of MMP9. Oncogene 25 5547-5560.
15. Falcon S & Gentleman R 2007 Using GOstats to test gene lists for GO term association. Bioinformatics 23 257-258.
16. Hanahan D & Weinberg RA 2000 The hallmarks of cancer. Cell 100 57-70.
17. Helczynska K, Larsson AM, Holmquist-Mengelbier L, Bridges E, Fredlund E, Borgquist S, Landberg G, Pahlman S & Jirstrom K 2008 Hypoxia-inducible factor- 2a correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Research 68 9212-9220.
18. Heldin CH, Landström M & Moustakas A 2009 Mechanism of TGF-β signalling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Current Opinion in Cell Biology 21 166-176.
19. Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg A, Gradin K et al. 2006 Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype. Cancer Cell 10 413-423.
20. 2 homeostasis by hypoxia-inducible factor 1a. Genes and Development 12 149-162.
21. Jögi A, Vallon-Christersson J, Holmquist L, Axelson H, Borg A & På hlman S 2004 Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Experimental Cell Research 295 469-487.
22. 2 sensing and cancer. Nature Reviews. Cancer 8 865-873.
23. Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A & Kikkawa F 2008 Involvement of SDF-1α/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. International Journal of Cancer 122 91-99.
24. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA & Massague J 2003 A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3 537-549.
25. Kidd M, Modlin IM, Shapiro MD, Camp RL, Mane SM, Usinger W & Murren JR 2007 CTGF, intestinal stellate cells and carcinoid fibrogenesis. World Journal of Gastroenterology 13 5208-5216. (Pubitemid 47527737)
26. Kim SY, Lee CH, Midura BV, Yeung C, Mendoza A, Hong SH, Ren L, Wong D, Korz W, Merzouk A et al. 2008 Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clinical & Experimental Metastasis 25 201-211.
27. Kimbro KS & Simons JW 2006 Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocrine-Related Cancer 13 739-749.
28. Kölby L, Bernhardt P, Ahlman H, Wängberg B, Johanson V, Wigander A, Forssell-Aronsson E, Karlsson S, Ahren B, Stenman G et al. 2001 A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake. American Journal of Pathology 158 745-755.
29. Modlin IM, Champaneria MC, Chan AK & Kidd M 2007 A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. American Journal of Gastroenterology 102 1464-1473.
30. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN et al. 2001 Involvement of chemokine receptors in breast cancer metastasis. Nature 410 50-56.
31. Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, Nestle FO & Hwang ST 2002 Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Research 62 7328-7334. (Pubitemid 36025256)
32. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H & Kishimoto T 1996 Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382 635-638.
33. Nevo I, Sagi-Assif O, Meshel T, Geminder H, Goldberg-Bittman L, Ben-Menachem S, Shalmon B, Goldberg I, Ben-Baruch A & Witz IP 2004 The tumor microenvironment: CXCR4 is associated with distinct protein expression patterns in neuroblastoma cells. Immunology Letters 92 163-169.
34. Palayoor ST, Mitchell JB, Cerna D, Degraff W, John-Aryankalayil M & Coleman CN 2008 PX-478, an inhibitor of hypoxia-inducible factor-1α, enhances radiosensitivity of prostate carcinoma cells. International Journal of Cancer 123 2430-2437.
35. Perigny M, Hammel P, Corcos O, Larochelle O, Giraud S, Richard S, Sauvanet A, Belghiti J, Ruszniewski P, Bedossa P et al. 2009 Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression. American Journal of Surgical Pathology 33 739-748.
36. Plöckinger U 2008 Biotherapy and chemotherapy. In Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach, pp 651-661. Eds I Jankowski, D Kerr & Y Fong. Wiley-Blackwell.
37. Pollak M 2008 Insulin and insulin-like growth factor signalling in neoplasia. Nature Reviews. Cancer 8 915-928.
38. Rindi G, Klöppel G, Couvelard A, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A et al. 2007 TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 451 757-762.
39. Roland J, Murphy BJ, Ahr B, Robert-Hebmann V, Delauzun V, Nye KE, Devaux C & Biard-Piechaczyk M 2003 Role of the intracellular domains of CXCR4 in SDF-1-mediated signalling. Blood 101 399-406.
40. Russell HV, Hicks J, Okcu MF & Nuchtern JG 2004 CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. Journal of Pediatric Surgery 39 1506-1511.
41. Sahlgren C, Gustafsson MV, Jin S, Poellinger L & Lendahl U 2008 Notch signalling mediates hypoxia-induced tumor cell migration and invasion. PNAS 105 6392-6397.
42. Semenza GL 2003 Targeting HIF-1 for cancer therapy. Nature Reviews. Cancer 3 721-732.
43. Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D & Luker GD 2004 CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Research 64 8604-8612.
44. Sun YX, Schneider A, Jung Y, Wang J, Dai J, Wang J, Cook K, Osman NI, Koh-Paige AJ, Shim H et al. 2005 Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. Journal of Bone and Mineral Research 20 318-329.
45. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S et al. 1998 The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393 591-594.
46. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS & McCauley LK 2002 Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Research 62 1832-1837. (Pubitemid 34408510)
47. Tian H, Hammer RE, Matsumoto AM, Russell DW & McKnight SL 1998 The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes and Development 12 3320-3324. (Pubitemid 28520979)
48. Toschi A, Lee E, Gadir N, Ohh M & Foster DA 2008 Differential dependence of hypoxia-inducible factors 1a and 2α on mTORC1 and mTORC2. Journal of Biological Chemistry 283 34495-34499.
49. Wouters BG & Koritzinsky M 2008 Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nature Reviews. Cancer 8 851-864.
50. Wright N, de Lera TL, Garcia-Moruja C, Lillo R, Garcia-Sanchez F, Caruz A & Teixido J 2003 Transforming growth factor-β1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion. Blood 102 1978-1984.
51. Yoon Y, Liang Z, Zhang X, Choe M, Zhu A, Cho HT, Shin DM, Goodman MM, Chen ZG & Shim H 2007 CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models. Cancer Research 67 7518-7524.
52. Zou YR, Kottmann AH, Kuroda M, Taniuchi I & Littman DR 1998 Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393 595-599.